Clinical and Safety Outcomes of Endovascular Therapy 6 to 24 Hours After Large Vessel Occlusion Ischemic Stroke With Tandem Lesions.

Carotid artery diseases Early window Ischemic stroke Late window Tandem lesions Thrombectomy

Journal

Journal of stroke
ISSN: 2287-6391
Titre abrégé: J Stroke
Pays: Korea (South)
ID NLM: 101602023

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 09 03 2023
accepted: 25 05 2023
medline: 23 8 2023
pubmed: 23 8 2023
entrez: 22 8 2023
Statut: ppublish

Résumé

Effect of endovascular therapy (EVT) in acute large vessel occlusion (LVO) patients with tandem lesions (TLs) within 6-24 hours after last known well (LKW) remains unclear. We evaluated the clinical and safety outcomes among TL-LVO patients treated within 6-24 hours. This multicenter cohort was divided into two groups, based on LKW to puncture time: early window (<6 hours), and late window (6-24 hours). Primary clinical and safety outcomes were 90-day functional independence measured by the modified Rankin Scale (mRS: 0-2) and symptomatic intracranial hemorrhage (sICH). Secondary outcomes were successful reperfusion (modified Thrombolysis in Cerebral Infarction score ≥2b), first-pass effect, early neurological improvement, ordinal mRS, and in-hospital and 90-day mortality. Of 579 patients (median age 68, 32.1% females), 268 (46.3%) were treated in the late window and 311 (53.7%) in the early window. Late window group had lower median National Institutes of Health Stroke Scale score at admission, Alberta Stroke Program Early Computed Tomography Score, rates of intravenous thrombolysis, and higher rates for perfusion imaging. After adjusting for confounders, the odds of 90-day mRS 0-2 (47.7% vs. 45.0%, adjusted odds ratio [aOR] 0.71, 95% confidence interval [CI] 0.49-1.02), favorable shift in mRS (aOR 0.88, 95% CI 0.44-1.76), and sICH (3.7% vs. 5.2%, aOR 0.56, 95% CI 0.20-1.56) were similar in both groups. There was no difference in secondary outcomes. Increased time from LKW to puncture did not predicted the probability of 90-day mRS 0-2 (aOR 0.99, 95% CI 0.96-1.01, for each hour delay) among patients presenting <24 hours. EVT for acute TL-LVO treated within 6-24 hours after LKW was associated with similar rates of clinical and safety outcomes, compared to patients treated within 6 hours.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Effect of endovascular therapy (EVT) in acute large vessel occlusion (LVO) patients with tandem lesions (TLs) within 6-24 hours after last known well (LKW) remains unclear. We evaluated the clinical and safety outcomes among TL-LVO patients treated within 6-24 hours.
METHODS METHODS
This multicenter cohort was divided into two groups, based on LKW to puncture time: early window (<6 hours), and late window (6-24 hours). Primary clinical and safety outcomes were 90-day functional independence measured by the modified Rankin Scale (mRS: 0-2) and symptomatic intracranial hemorrhage (sICH). Secondary outcomes were successful reperfusion (modified Thrombolysis in Cerebral Infarction score ≥2b), first-pass effect, early neurological improvement, ordinal mRS, and in-hospital and 90-day mortality.
RESULTS RESULTS
Of 579 patients (median age 68, 32.1% females), 268 (46.3%) were treated in the late window and 311 (53.7%) in the early window. Late window group had lower median National Institutes of Health Stroke Scale score at admission, Alberta Stroke Program Early Computed Tomography Score, rates of intravenous thrombolysis, and higher rates for perfusion imaging. After adjusting for confounders, the odds of 90-day mRS 0-2 (47.7% vs. 45.0%, adjusted odds ratio [aOR] 0.71, 95% confidence interval [CI] 0.49-1.02), favorable shift in mRS (aOR 0.88, 95% CI 0.44-1.76), and sICH (3.7% vs. 5.2%, aOR 0.56, 95% CI 0.20-1.56) were similar in both groups. There was no difference in secondary outcomes. Increased time from LKW to puncture did not predicted the probability of 90-day mRS 0-2 (aOR 0.99, 95% CI 0.96-1.01, for each hour delay) among patients presenting <24 hours.
CONCLUSION CONCLUSIONS
EVT for acute TL-LVO treated within 6-24 hours after LKW was associated with similar rates of clinical and safety outcomes, compared to patients treated within 6 hours.

Identifiants

pubmed: 37607694
pii: jos.2023.00759
doi: 10.5853/jos.2023.00759
pmc: PMC10574302
doi:

Types de publication

Journal Article

Langues

eng

Pagination

378-387

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS110980
Pays : United States
Organisme : NINDS NIH HHS
ID : R21 NS130423
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109089
Pays : United States
Organisme : NINDS NIH HHS
ID : R03 NS126804
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS127114
Pays : United States

Références

N Engl J Med. 1994 Jun 2;330(22):1565-70
pubmed: 8177246
J Neurointerv Surg. 2019 Oct;11(10):970-974
pubmed: 30842304
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
JACC Cardiovasc Interv. 2018 Jul 9;11(13):1290-1299
pubmed: 29976365
Stroke. 2015 Oct;46(10):2981-6
pubmed: 26330447
Arch Neurol. 2012 Dec;69(12):1615-20
pubmed: 23007611
Lancet. 2022 Jan 15;399(10321):249-258
pubmed: 34774198
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
Stroke. 2021 Oct;52(10):3097-3105
pubmed: 34372671
Arch Neurol. 2009 Dec;66(12):1523-8
pubmed: 20008658
J Am Heart Assoc. 2022 Jan 18;11(2):e022335
pubmed: 35023353
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
Bull World Health Organ. 2007 Nov;85(11):867-72
pubmed: 18038077
J Neurointerv Surg. 2015 Jan;7(1):16-21
pubmed: 24401478
N Engl J Med. 2008 Sep 25;359(13):1317-29
pubmed: 18815396
Stroke. 2019 Aug;50(8):2250–2252
pubmed: 31577899
Ann Indian Acad Neurol. 2020 Jan-Feb;23(1):13-19
pubmed: 32055116
N Engl J Med. 1998 Nov 12;339(20):1415-25
pubmed: 9811916
Arch Neurol. 2001 Apr;58(4):613-7
pubmed: 11295992
Med Sci Monit. 2016 Dec 16;22:4954-4959
pubmed: 27984560
Stroke. 2019 Jul;50(7):1797-1804
pubmed: 31159701
Stroke. 2006 Sep;37(9):2301-5
pubmed: 16888266
JAMA Netw Open. 2023 Mar 1;6(3):e230736
pubmed: 36857054
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Stroke. 2017 Sep;48(9):2621-2627
pubmed: 28794271
Stroke. 2017 Nov;48(11):3145-3148
pubmed: 28974628
N Engl J Med. 2020 Jun 11;382(24):2316-2326
pubmed: 32521133
Front Neurol. 2019 Mar 11;10:206
pubmed: 30915023

Auteurs

Milagros Galecio-Castillo (M)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

Mudassir Farooqui (M)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

Ameer E Hassan (AE)

Department of Neurology, Valley Baptist Medical Center/University of Texas Rio Grande Valley, Harlingen, TX, USA.

Mouhammad A Jumaa (MA)

Department of Neurology, ProMedica Toledo Hospital, Toledo, OH, USA.

Afshin A Divani (AA)

Department of Neurology, University of New Mexico Health Science Center, Albuquerque, NM, USA.

Marc Ribo (M)

Department of Neurology, Hospital Vall d'Hebron, Barcelona, Spain.

Michael Abraham (M)

Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.

Nils H Petersen (NH)

Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.

Johanna T Fifi (JT)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Waldo R Guerrero (WR)

Department of Neurology and Brain Repair, University of South Florida, Tampa, FL, USA.

Amer M Malik (AM)

Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.

James E Siegler (JE)

Cooper Neurological Institute, Cooper University Hospital, Camden, NJ, USA.
Cooper Medical School of Rowan University, Camden, NJ, USA.

Thanh N Nguyen (TN)

Department of Neurology, Boston Medical Center, Boston, MA, USA.

Sunil Sheth (S)

Department of Neurology, UT Health McGovern Medical School, Houston, TX, USA.

Albert J Yoo (AJ)

Texas Stroke Institute, Dallas-Fort Worth, TX, USA.

Guillermo Linares (G)

Department of Neurology, Saint Louis University, St. Louis, MO, USA.

Nazli Janjua (N)

Asia Pacific Comprehensive Stroke Institute, Pomona Valley Hospital Medical Center, Pomona, CA, USA.

Darko Quispe-Orozco (D)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

Wondwossen Tekle (W)

Department of Neurology, Valley Baptist Medical Center/University of Texas Rio Grande Valley, Harlingen, TX, USA.

Syed F Zaidi (SF)

Department of Neurology, ProMedica Toledo Hospital, Toledo, OH, USA.

Sara Y Sabbagh (SY)

Department of Neurology, University of New Mexico Health Science Center, Albuquerque, NM, USA.

Marta Olivé-Gadea (M)

Department of Neurology, Hospital Vall d'Hebron, Barcelona, Spain.

Tiffany Barkley (T)

Department of Neurology, University of Kansas Medical Center, Kansas City, KS, USA.

Reade De Leacy (R)

Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Kenyon W Sprankle (KW)

Cooper Medical School of Rowan University, Camden, NJ, USA.

Mohamad Abdalkader (M)

Department of Radiology, Boston Medical Center, Boston, MA, USA.

Sergio Salazar-Marioni (S)

Department of Neurology, UT Health McGovern Medical School, Houston, TX, USA.

Jazba Soomro (J)

Texas Stroke Institute, Dallas-Fort Worth, TX, USA.

Weston Gordon (W)

Department of Neurology, Saint Louis University, St. Louis, MO, USA.

Charoskhon Turabova (C)

Asia Pacific Comprehensive Stroke Institute, Pomona Valley Hospital Medical Center, Pomona, CA, USA.

Juan Vivanco-Suarez (J)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

Aaron Rodriguez-Calienes (A)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

Maxim Mokin (M)

Department of Neurology and Brain Repair, University of South Florida, Tampa, FL, USA.

Dileep R Yavagal (DR)

Department of Neurology, University of Miami Miller School of Medicine, Miami, FL, USA.

Tudor Jovin (T)

Cooper Neurological Institute, Cooper University Hospital, Camden, NJ, USA.
Cooper Medical School of Rowan University, Camden, NJ, USA.

Santiago Ortega-Gutierrez (S)

Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.

Classifications MeSH